Revolution Medicines revenue and financials
$199.87Change from previous close: −3.76%Absolute change: −$7.81
Fiscal year ending in December. Sources and method on the page Methodology and sources.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -898 | -557 | -351 | -224 | -147 | -100 | -49.6 | 1.2 |
| Depreciation and amortization | 7.8 | 6.6 | 5.0 | 4.0 | 3.1 | 2.6 | 2.3 | 1.6 |
| Capital expenditure | -16.0 | -10.3 | -7.7 | -10.8 | -6.5 | -2.9 | -2.6 | -1.5 |
| Investing cash flow | 118 | -554 | -343 | -24.1 | -142 | — | — | — |
| Financing cash flow | 622 | 959 | 1,229 | 301 | 294 | — | — | — |
| Dividends paid | — | — | — | — | — | 0.0 | — | — |
| Share repurchases | — | — | -4.0 | — | — | — | — | — |
| Net change in cash | -158 | -152 | 536 | 52.9 | 4.9 | — | — | — |
| Free cash flow | -914 | -568 | -358 | -235 | -154 | — | — | — |
| Levered free cash flow | -523 | -348 | -164 | -133 | -84.7 | — | — | — |